Medicxi Ventures Management (Jersey) Ltd Portfolio Stock Holdings

According to the SEC 13F filed on August 4, 2026, Medicxi Ventures Management (Jersey) Ltd disclosed 3 stock positions valued at approximately $177.42M as of quarter-end June 30, 2026. The largest holdings include PHATHOM PHARMACEUTICALS INC, NEWAMSTERDAM PHARMA COMPANY, and AURA BIOSCIENCES INC.

Report Period: June 30, 2026
No. of Stocks: 3
Portfolio Value: $177.42M

Holdings by Sector

Medicxi Ventures Management (Jersey) Ltd Portfolio Holdings in Q2 2026

Company	Symbol	Sector	Portfolio %	Shares	Change (Shares)	Change %	Value
PHATHOM PHARMACEUTICALS INC	PHAT	Healthcare	45.65%	7,464,572	-	-	$80,990,606
NEWAMSTERDAM PHARMA COMPANY	NAMSW	Other	42.19%	2,208,639	-465,543	-17.41%	$74,850,776
AURA BIOSCIENCES INC	AURA	Healthcare	12.16%	3,039,892	-	-	$21,583,233

Showing 3 of 3 holdings in the latest reporting period.